EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Bitter Taste Receptor Agonists Induce Apoptosis in Papillary Thyroid Cancer

Kimberly Wei iD, Brianna L Hill, Joel C Thompson, Zoey A Miller, Arielle Mueller, Robert J Lee, Ryan M Carey iD

Head & Neck · 2025

DOI: 10.1002/hed.28120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, 2025. Verfasst von Kimberly Wei und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology - Head and Neck Surgery, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Apoptosis, Thyroid Cancer, Papillary, Thyroid Neoplasms, Receptors, G-Protein-Coupled. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: McCabe Foundation Fellowship, NIDCD NIH HHS, American Head and Neck Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Papillary thyroid carcinoma (PTC) is the most common thyroid malignancy, with a 20% recurrence rate. Bitter taste receptors (T2Rs) and their genes ( TAS2Rs ) may regulate survival in solid tumors. This study examined T2R expression and function in PTC cells.

Methods

Three PTC cell lines (MDA‐T32, MDA‐T68, and MDA‐T85) were analyzed for expression using RT‐qPCR and immunofluorescence. Live cell imaging measured calcium responses to six bitter agonists. Viability and apoptosis effects were assessed using crystal violet and caspase 3/7 activation assays. Genome analysis of survival was conducted.

Results

TAS2R14 was consistently highly expressed in all cell lines. Five bitter agonists produced significant cytoplasmic and mitochondrial calcium responses across all cell lines. All bitter agonists significantly decreased viability and induced apoptosis. Higher TAS2R14 expression correlated with better progression‐free survival in patients ( p < 0.05).

Conclusions

T2R activation by bitter agonists induces apoptosis, and higher TAS2R expression is associated with survival, suggesting potential therapeutic relevance in thyroid cancer management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisThyroid Cancer, PapillaryThyroid NeoplasmsReceptors, G-Protein-CoupledHumansTaste Receptors, Type 2Cell Line, TumorCell SurvivalFemale

Stichwörter der Autor:innen

apoptosiscalciumcell signalingpapillary thyroid cancertaste receptors

Substanzen

Receptors, G-Protein-CoupledTaste Receptors, Type 2

Autor:innen und Institutionen

  • Department of Otorhinolaryngology - Head and Neck Surgery, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Department of Physiology, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Kimberly Wei, Ryan M Carey

Förderung

  • McCabe Foundation Fellowship
  • NIDCD NIH HHS
  • American Head and Neck Society
  • NIAID NIH HHS
  • National Institutes of Health, National Institute of Allergy and Infectious Diseases
  • National Institutes of Health

Zitieren

APA

Wei, K., Hill, B. L., Thompson, J. C., Miller, Z. A., Mueller, A., Lee, R. J., & Carey, R. M. (2025). Bitter Taste Receptor Agonists Induce Apoptosis in Papillary Thyroid Cancer. Head & Neck. https://doi.org/10.1002/hed.28120

Vancouver

Wei K, Hill BL, Thompson JC, Miller ZA, Mueller A, Lee RJ, et al. Bitter Taste Receptor Agonists Induce Apoptosis in Papillary Thyroid Cancer. Head & Neck. 2025. doi:10.1002/hed.28120

BibTeX
@article{Wei2025,
  author = {Wei, Kimberly and Hill, Brianna L and Thompson, Joel C and Miller, Zoey A and Mueller, Arielle and Lee, Robert J and Carey, Ryan M},
  title = {Bitter Taste Receptor Agonists Induce Apoptosis in Papillary Thyroid Cancer},
  journal = {Head & Neck},
  year = {2025},
  doi = {10.1002/hed.28120}
}
Kostenlos starten →